Physician

Carolyn Elizabeth Haunschild, M.D.

According to 2025 Medicare claims, Carolyn Haunschild, M.D. (NPI: 1912319880) practices gynecologist/oncologist in the Los Angeles-Long Beach-Glendale, CA market, with the plurality of this provider's patient population coming from Los Angeles, CA. This provider's primary affiliated billing organization is REGENTS OF THE UNIVERSITY OF CALIFORNIA (NPI: 1609839067; TIN: 954716870) and primary practice location at 90095-0001. Haunschild is affiliated with the UC Irvine Health Accountable Care Organization (ACO ID: A3799), participating under the MSSP model.

Haunschild's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 79 traditional Medicare patients, billed 367 HCPCS/CPT codes, and received $53,340 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 110 prescription claims across 37 beneficiaries totaling $77,859 in drug costs, led by Neomycin Sulfate (Neomycin Sulfate). Open Payments data shows 9 records totaling $7,663. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $172 to $77,859. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$27K$54K2022 Medicare payment: $13,347 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $53,901 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $53,340 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
20222864$13,347
202367241$53,901
202479367$53,340

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$282K$564K2017 Drug cost: $172 (USD; Tot_Drug_Cst)2018 Drug cost: $340 (USD; Tot_Drug_Cst)2019 Drug cost: $1,580 (USD; Tot_Drug_Cst)2020 Drug cost: $1,884 (USD; Tot_Drug_Cst)2021 Drug cost: $563,793 (USD; Tot_Drug_Cst)2022 Drug cost: $12,409 (USD; Tot_Drug_Cst)2023 Drug cost: $3,815 (USD; Tot_Drug_Cst)2024 Drug cost: $77,859 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
20171214$172
20181315$340
20191427$1,580
20203265$1,884
202182248$563,793
202246126$12,409
20232475$3,815
202437110$77,859

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99205New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more1313$181
99215Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more3093$149
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more2639$95
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more3152$76
99459Pelvic exam4469$20

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Neomycin SulfateNeomycin Sulfate1313$56
MetronidazoleMetronidazole1414$14

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.7$977INTUITIVE SURGICAL, INC.
Research PaymentsReported research-related payment or transfer-of-value amount.2$6,687Karyopharm Therapeutics Inc.
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Carolyn Elizabeth Haunschild, M.D.?

Tedicare shows public-source Medicare data for Carolyn Elizabeth Haunschild, M.D. (NPI 1912319880), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Carolyn Elizabeth Haunschild, M.D. have ACO affiliation data?

Carolyn Elizabeth Haunschild, M.D. is shown with ACO affiliation data for UC Irvine Health Accountable Care Organization (MSSP, ACO ID A3799).

What billing organization is linked to Carolyn Elizabeth Haunschild, M.D.?

Carolyn Elizabeth Haunschild, M.D. is linked to REGENTS OF THE UNIVERSITY OF CALIFORNIA (billing NPI 1609839067) in the available physician profile data.

Does Carolyn Elizabeth Haunschild, M.D. have Open Payments data?

Carolyn Elizabeth Haunschild, M.D. has 9 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.